Soluble Epoxide Hydrolase Inhibitor, TPPU, Attenuates Progression of Atherosclerotic Lesions and Vascular Smooth Muscle Cell Phenotypic Switching

Researchers investigated the therapeutic effect of (trifluoromethoxy)phenyl]-urea (TPPU) on atherosclerosis in vivo and homocysteine-induced vascular inflammation in vitro and explored their molecular mechanisms.